| Tofacitinib citrate |
枸橼酸托法替尼 |
540737-29-9 |
| Methanone, [(3R)-3-fluoro-1-pyrrolidinyl][6-[[5-(trifluoromethyl)-2-pyridinyl]oxy]-2-quinolinyl]- |
ABBV-318 |
1802848-94-7 |
| BI-3406 |
BI-3406 |
2230836-55-0 |
| GPR40/FFAR1 modulator 1 |
GPR40/FFAR1 modulator 1 |
874755-26-7 |
| BZAD01 |
BZAD01 |
305339-41-7 |
| BI-2865 |
(4S)-2-氨基-4,5,6,7-四氢-4-甲基-4-[3-[4-[(1S)-1-[(2S)-1-甲基-2-吡咯烷基]乙氧基]-2-嘧啶基]-1,2,4-恶二唑-5-基]苯并[B]噻吩-3-甲腈 |
2937327-93-8 |
| TNG260 |
TNG260 |
2935964-98-8 |
| Tube2156 |
Tube2156 |
2882165-79-7 |
| 1-Piperidineacetamide, N-(6-amino-5-methyl-3-pyridinyl)-2-(5-benzothiazolyl)-5-methyl-α-oxo-, (2R,5S)- |
1-PIPERIDINEACETAMIDE, N-(6-AMINO-5-METHYL-3-PYRIDINYL)-2-(5-BENZOTHIAZOLYL)-5-METHYL-Α-OXO-, (2R,5S)-试剂 |
2760481-53-4 |
| BAY 2965501 |
(2R)-2-[[4-氨基-5-(4-甲氧基苯甲酰基)-2-噻唑基](4-氟苯基)氨基]丙酰胺 |
2732902-08-6 |
| RMC6291 |
(3S)-N1-[N-[[1-[4-(二甲基氨基)-4-甲基-1-氧代-2-戊炔-1-基]-4-氟-4-哌啶基]羰基]-N-甲基-L-缬氨酰基-3-[4-[(2R)-1-乙基-3-(3-羟基-2,2-二甲基丙基)-2-[2-[(1S)-1-甲氧基乙基]-3-吡啶基]-1H-吲哚-5-基]-2-吗啉基]-L-丙氨酰基]六氢-3-哒嗪甲酸(3→2)-内酯 |
2641998-63-0 |
| Pyridine, 3-[(4R)-2-hydroxy-1,2-oxaborolan-4-yl]-5-(4-methoxy-3-propoxyphenyl)- |
PF-07038124 |
2415085-44-6 |
| EZM0414 |
EZM0414 |
2411748-50-8 |
| OSMI-4 |
OSMI-4 |
2260791-14-6 |
| 1H-1,2,3-Triazole-4-carboxamide, 1-(1,1-dimethylethyl)-N-[(5R)-2,3,4,5-tetrahydro-8-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-2-(3-oxetanyl)-1H-2-benzazepin-5-yl]- |
1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-[(5R)-2,3,4,5-TETRAHYDRO-8-[2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]-4-PYRIMIDINYL]-2-(3-OXETANYL)-1H-2-BENZ |
2247614-80-6 |
| dBRD9 |
DBRD9 |
2170679-45-3 |
| 2091134-35-7 |
JAK1-IN-4 |
2091134-35-7 |
| tert-butyl (R)-(4,4-difluoropiperidin-3-yl)carbamate(WX900188) |
(R)-叔-丁基 (4,4-二氟哌啶-3-基)氨基甲酯 |
2089321-22-0 |
| BMS-986260 |
BMS986260 |
2001559-19-7 |
| Levothyroxine Sodium impurity |
左甲状腺素钠杂质 |
27566-09-2 |
QQ
微信
